
Exploring hCG Monotherapy and Exogenous Testosterone in Young Men with Hypogonadotropic Hypogonadism: A Focus on Testicular Function
Reading Time: 2 minutes Introduction Hypogonadotropic hypogonadism (HH) in young men presents a unique challenge in endocrinology, particularly in the United States where lifestyle and environmental factors can significantly influence hormonal health. The management of HH often involves hormone replacement therapy, with two primary options being human chorionic gonadotropin (hCG) monotherapy and exogenous testosterone. This article delves into the comparative outcomes of these treatments on testicular function, specifically tailored to the needs and concerns of American males. Understanding Hypogonadotropic Hypogonadism Hypogonadotropic hypogonadism is characterized by a deficiency in gonadotropin-releasing hormone (GnRH), leading to decreased secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This...